UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  February 1, 2013

 
QUICK-MED TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)

 
 
 
Nevada
000-27545
65-0797243
(State or other jurisdiction
(Commission
(IRS Employer
of incorporation)
File Number)
Identification No.)

 
 
902 NW 4th Street
Gainesville, Florida
32601
(Address of principal executive offices)
(Zip Code)

Registrant's telephone number, including area code (888) 835-2211
 
              ___________________________________________________________________________________________________________
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 
 
Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers, Compensatory Arrangements of Certain Officers.
(b)            Departure of Director
Effective January 28, 2013, J. Ladd Greeno resigned as a member and Chairman of the Board of Directors of the Registrant.
There were no disagreements between Mr. Greeno and any officer or director of the Registrant that caused his resignation.  The Registrant provided a copy of the disclosures it is making in response to this Item 5.02 to Mr. Greeno and informed him that he may furnish the Registrant as promptly as possible with a letter stating whether he agrees or disagrees with the disclosures made in response to this Item 5.02, and that if he disagrees, then the Registrant requests that he provides the respects in which he does not agree with the disclosures. The Registrant will undertake to file any letter received from Mr. Greeno, if any, as an exhibit to an amendment to this current report on Form 8-K within two business days after receipt.


 




 

 
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
QUICK-MED TECHNOLOGIES, INC.
 
(Registrant)
 
 
 
Date:  February 1, 2013
                                       /s/  Bernd Liesenfeld
 
Bernd Liesenfeld, President